The Know All Your Treatment Options virtual event is presented annually by the End Brain Cancer Initiative. We bring together medical professionals, caregivers and patients with the following objectives :
Learn
Be inspired
Share
The event was recorded and the full event video is available using the button below. Descriptions of the individual presentations and direct links to those sections of the video are available as you scroll down this page.
Director: Stereotactic/Functional/Epilepsy Fellowship Program Co-Director: Neurosurgical Oncology and Radiosurgery Director: NPH and Hypothalamic Hamartoma Programs Barrow Neurological Institute
Dr. Kris Smith
Advances in Treating Patients GammaTile Combined with Ketogenic Metabolic Therapy: A Better Chance for Long-Term Survival and QOL Preservation?
Dr. Kris Smith describes his father’s GBM journey that led to Dr. Smith’s insight into the disease, its cause and treatment. He advocates the use of metabolic treatment based on a ketogenic diet combined with radiation and chemotherapy treatments. Dr. Smith describes the GammaTile device, which is an implanted radiation source.
Neuro-Oncologist, University of Washington Medicine and Seattle Cancer Alliance Assistant Professor, Division of Medical Oncology University of Washington School of Medicine Assistant Professor, Clinical Research Division Fred Hutchinson Cancer Research Center
Dr. Vyshak Venur
Clinical Trials in Treating Brain Tumors The Current Clinical Trial Landscape for Patients with Primary Brain Tumors
Dr. Venur discusses the drug development process and the importance of clinical trials. Patients can enter a trial at various points in their treatment and disease progression. In this talk, Dr. Venur describes ongoing trials in the areas of targeted therapies, novel systemic therapies, immunotherapy, and medical devices.
Neurosurgeon, University of Washington School of Medicine and Seattle Cancer Care Alliance Assistant Professor, Department of Neurological Surgery, University of Washington School of Medicine
Dr. Anoop Patel
Brain Tumor Tissue Profiling Surgical Trials and Future Directions in Brain Tumor Treatment
Dr. Patel provides an overview of the types of brain tumors and their treatments. He discusses the development of new treatments through surgical trials including interventional trials and tissue sampling trials. Precision medicine, a personalize approach based on single-cell sequencing of tumor samples, has great promise for new brain cancer treatments.
Dr. Piet Hanoul describes the science behind tumor-treating fields, which are low-intensity, intermediate frequency, alternating electric fields. These fields deliver energy at a distance that disrupts the cell division process. The frequency of the tumor-treating fields can be tuned to impact specific cancers. Novocure has developed the Optune medical device, based on tumor-treating fields, for the treatment of brain cancer.
Jeanneane was diagnosed with grade-4 GBM in her 30’s. Her treatment followed the standard of care along with a special diet and the use of the Optune medical device. Jeanneane describes how the disease changed her life and caused a feeling of a loss of control, but she remains hopeful and has learned to be trusting of her medical team, caregivers, and family.
Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.
